tirzepatide glp gip Tirzepatide: A Double Approach to Diabetes and Weight Loss Retatrutide vs Tirzepatide vs Semaglutide

Your GP or diabetes specialist will determine your appropriate dose based on clinical assessment, monitoring, and NICE guidance

: : 500-1000 : : 500 : L- L-

Methods GLP-1 agonists included in the analysis were approved for treatment of obesity (Saxenda, Wegovy, Zepbound) and corresponding formulations that may potentially be used off-label for treatment of obesity (Mounjaro, Ozempic, Rybelsus, Victoza)

How Tirzepatide Works in the Body Tirzepatide is a unique medication known as a dual agonist

In January 2026, the FDA approved oral semaglutide (Wegovy in pill form) for weight managementthe first GLP-1 receptor agonist available as a pill for weight loss